Topical immunomodulators for atopic dermatitis
- 1 August 2002
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Pediatrics
- Vol. 14 (4) , 414-418
- https://doi.org/10.1097/00008480-200208000-00010
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part I, efficacyJournal of the American Academy of Dermatology, 2001
- Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part II, safetyJournal of the American Academy of Dermatology, 2001
- A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patientsJournal of the American Academy of Dermatology, 2001
- Safety and Efficacy of 1 Year of Tacrolimus Ointment Monotherapy in Adults With Atopic DermatitisArchives of Dermatology, 2000
- Atopic dermatitis-like symptoms in hypomagnesaemic hairless rats are prevented and inhibited by systemic or topical SDZ ASM 981British Journal of Dermatology, 2000
- A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacologyBritish Journal of Dermatology, 1999
- A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in childrenJournal of Allergy and Clinical Immunology, 1998
- A Short-Term Trial of Tacrolimus Ointment for Atopic DermatitisNew England Journal of Medicine, 1997
- Granulocyte macrophage colony-stimulating factor contributes to enhanced monocyte survival in chronic atopic dermatitis.Journal of Clinical Investigation, 1995
- Shifts in interleukin-4 and interferon-γ production by T cells of patients with elevated serum IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesisJournal of Allergy and Clinical Immunology, 1991